NEW YORK, Sept. 3 (GenomeWeb News) - Quorex Pharmaceuticals of Carlsbad, Calif., and IDEC Pharmaceuticals of San Diego today announced a research collaboration seeking novel genes encoding proteins for use as therapeutic targets for cancers and inflammatory disorders.

Quorex will apply its Protein Vision bioinformatics tools -- which include genome annotation, homology modeling, and protein-fold prediction tools -- and receive undisclosed up-front and research payments.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.